These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial. Conde-Martel A, Trullàs JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sánchez-Marteles M, Llácer P, Salamanca-Bautista P, Manzano L, Formiga F. Rev Clin Esp (Barc); 2024 Feb; 224(2):67-76. PubMed ID: 38215973 [Abstract] [Full Text] [Related]
7. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial. Martens P, Dauw J, Verbrugge FH, Nijst P, Meekers E, Augusto SN, Ter Maaten JM, Damman K, Mebazaa A, Filippatos G, Ruschitzka F, Tang WHW, Dupont M, Mullens W. Circulation; 2023 Jan 17; 147(3):201-211. PubMed ID: 36335479 [Abstract] [Full Text] [Related]
8. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA, Ter Maaten JM, Houser SR, Vedage NA, Rao V, Ahmad T, Wilson FP, Testani JM. J Am Heart Assoc; 2018 Sep 18; 7(18):e009149. PubMed ID: 30371181 [Abstract] [Full Text] [Related]
14. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Mouallem M, Brif I, Mayan H, Farfel Z. Int J Cardiol; 1995 Jun 30; 50(2):89-94. PubMed ID: 7591335 [Abstract] [Full Text] [Related]
16. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes. Miró Ò, Núñez J, Trullàs JC, Lopez-Ayala P, Llauger L, Alquézar-Arbé A, Miñana G, Mollar A, de la Espriella R, Lorenzo M, Jacob J, Espinosa B, Garcés-Horna V, Aguirre A, Fortuny MJ, Martínez-Nadal G, Gil V, Mueller C, Llorens P, ICA-SEMES, INCLIVA, ALCALOTIC research groups. Eur J Intern Med; 2024 Sep 30; 127():126-133. PubMed ID: 38763846 [Abstract] [Full Text] [Related]
17. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics. Mullens W, Dauw J, Martens P, Meekers E, Nijst P, Verbrugge FH, Chenot F, Moubayed S, Dierckx R, Blouard P, Derthoo D, Smolders W, Ector B, Hulselmans M, Lochy S, Raes D, Van Craenenbroeck E, Vandekerckhove H, Hofkens PJ, Goossens K, Pouleur AC, De Ceuninck M, Gabriel L, Timmermans P, Prihadi EA, Van Durme F, Depauw M, Vervloet D, Viaene E, Vachiery JL, Tartaglia K, Ter Maaten JM, Bruckers L, Droogne W, Troisfontaines P, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M. Eur J Heart Fail; 2022 Sep 30; 24(9):1601-1610. PubMed ID: 35733283 [Abstract] [Full Text] [Related]
18. Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease. Hoshino T, Ookawara S, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hirai K, Mori H, Yoshida I, Tabei K. Clin Exp Nephrol; 2015 Apr 30; 19(2):247-53. PubMed ID: 24821289 [Abstract] [Full Text] [Related]
19. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Dormans TP, Gerlag PG. Eur Heart J; 1996 Dec 30; 17(12):1867-74. PubMed ID: 8960430 [Abstract] [Full Text] [Related]
20. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial. Rohde LE, Rover MM, Figueiredo Neto JA, Danzmann LC, Bertoldi EG, Simões MV, Silvestre OM, Ribeiro ALP, Moura LZ, Beck-da-Silva L, Prado D, Sant'Anna RT, Bridi LH, Zimerman A, Raupp da Rosa P, Biolo A. Eur Heart J; 2019 Nov 21; 40(44):3605-3612. PubMed ID: 31424503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]